Juno Therapeutics, Inc. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Juno Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Juno Therapeutics, Inc. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2018 | JUNO | Juno Therapeutics, ... | FLATLEY JAY T | Director | Buy | P | 22.92 | 10,000 | 229,200 | 31,500 | 21.5 K to 31.5 K (+46.51 %) |
| Jan 24 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 51.76 | 102,539 | 5,307,419 | 97,461 | |
| Jan 24 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 86.25 | 102,539 | 8,843,989 | 70,832 | 173.4 K to 70.8 K (-59.14 %) |
| Jan 24 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 51.76 | 102,539 | 5,307,419 | 173,371 | 70.8 K to 173.4 K (+144.76 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 20.76 | 26,633 | 552,901 | 101,208 | |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 25.29 | 2,498 | 63,174 | 30,836 | |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 69.95 | 7,990 | 558,901 | 70,832 | 78.8 K to 70.8 K (-10.14 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 68.10 | 21,141 | 1,439,702 | 78,822 | 100 K to 78.8 K (-21.15 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 20.76 | 26,633 | 552,901 | 99,963 | 73.3 K to 100 K (+36.32 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 25.29 | 2,498 | 63,174 | 73,330 | 70.8 K to 73.3 K (+3.53 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 20.76 | 26,633 | 552,901 | 101,208 | |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 25.29 | 2,498 | 63,174 | 30,836 | |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 69.95 | 7,990 | 558,901 | 70,832 | 78.8 K to 70.8 K (-10.14 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 68.10 | 21,141 | 1,439,702 | 78,822 | 100 K to 78.8 K (-21.15 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 20.76 | 26,633 | 552,901 | 99,963 | 73.3 K to 100 K (+36.32 %) |
| Jan 19 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 25.29 | 2,498 | 63,174 | 73,330 | 70.8 K to 73.3 K (+3.53 %) |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 245,750 | 1,562,970 | 451,756 | |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 48.56 | 42,457 | 2,061,916 | 2,502,429 | 2.5 M to 2.5 M (-1.67 %) |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 47.69 | 23,003 | 1,097,071 | 2,544,886 | 2.6 M to 2.5 M (-0.90 %) |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 46.52 | 49,082 | 2,283,525 | 2,567,889 | 2.6 M to 2.6 M (-1.88 %) |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 45.53 | 89,888 | 4,092,789 | 2,616,971 | 2.7 M to 2.6 M (-3.32 %) |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 44.72 | 65,820 | 2,943,227 | 2,706,859 | 2.8 M to 2.7 M (-2.37 %) |
| Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 245,750 | 1,562,970 | 2,772,679 | 2.5 M to 2.8 M (+9.73 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 417 | 0 | 130,050 | 129.6 K to 130.1 K (+0.32 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 25,000 | 0 | 129,633 | 154.6 K to 129.6 K (-16.17 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Grant | A | 0.00 | 237 | 0 | 54,058 | 53.8 K to 54.1 K (+0.44 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 49.37 | 918 | 45,321 | 728,775 | 729.7 K to 728.8 K (-0.13 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 48.95 | 4,846 | 237,223 | 729,693 | 734.5 K to 729.7 K (-0.66 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 47.80 | 5,011 | 239,538 | 734,539 | 739.6 K to 734.5 K (-0.68 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 46.85 | 1,949 | 91,310 | 739,550 | 741.5 K to 739.6 K (-0.26 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 248 | 0 | 741,499 | 741.3 K to 741.5 K (+0.03 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 150 | 0 | 59,842 | 59.7 K to 59.8 K (+0.25 %) |
| Jan 09 2018 | JUNO | Juno Therapeutics, ... | Barron Hal | Director | Grant | A | 0.00 | 336 | 0 | 103,780 | 103.4 K to 103.8 K (+0.32 %) |